arrow
P

Patrick A. Flume

medical university of south carolina
H指数:57
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Omadacycline Monotherapy in Nontuberculous Mycobacterial Pulmonary Disease Caused by Mycobacterium abscessus: Results From a Phase 2, Double-blind, Randomized, Placebo-controlled Study

奥马环素单药治疗由分枝杆菌属脓肿分枝杆菌引起的非结核分枝杆菌肺部疾病:一项2期、双盲、随机、安慰剂对照研究的结果

2026-03-030
PRE
Structure of a Bronchiectasis and NTM Care Center: a Position Statement by the Bronchiectasis & NTM Association

支气管扩张与NTM护理中心的架构:支气管扩张与NTM协会立场声明

CHEST
IF8.6
2025-12-180
PRE
European Respiratory Society clinical practice guideline for the management of adult bronchiectasis

Chalmers, J.D.; Haworth, C.S.; Flume, P.; Long, M.B.; Burgel, P.R.; Dimakou, K.; Blasi, F.; Herrero-Cortina, B.; Dhar, R.; Chotirmall, S.H.; 等. 欧洲呼吸学会成人支气管扩张管理临床实践指南. Eur. Respir. J. 2025; 2501126, online ahead of print. [Google Scholar] [CrossRef]

2025-12-0122
PRE
PRenatal mOdulator treatment to PrEvent CF complicaTions (PROTECT) workshop report

PRenatal mOdulator治疗以预防CF并发症 (PROTECT) 工作坊报告

2025-08-050
OAAI
A Phase IIa, Single-Blind, Placebo-Controlled, Parallel-Group Study to Assess Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Brensocatib in Adults with Cystic Fibrosis

一项IIa期、单盲、安慰剂对照、平行分组研究,旨在评估布伦索卡替在囊性纤维化成人中的安全性、耐受性以及药代动力学/药效动力学

2025-08-030
OAAI
Cannabinoid receptor 2 agonist, lenabasum, for the treatment of pulmonary exacerbations in cystic fibrosis

大麻素受体2激动剂lenabasum,用于治疗囊性纤维化患者的肺病急性加重。

2025-05-260
PRE